The impact of patent expiry on drug prices: insights from the Dutch market.

van der Schans, Simon; Vondeling, Gert T; Cao, Qi; van der Pol, Simon; Visser, Sipke; Postma, Maarten J; Rozenbaum, Mark H.

Afiliação

van der Schans S; Unit of Global Health, Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
Vondeling GT; Fair Medicine Foundation, Amsterdam, The Netherlands.
Cao Q; Department of Global Market Access & Pricing, Daiichi Sankyo, München, Germany.
van der Pol S; Unit of Global Health, Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
Visser S; Unit of PharmacoTherapy, -epidemiology & -economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
Postma MJ; Unit of Global Health, Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
Rozenbaum MH; Data Scientia, Groningen, The Netherlands.

J Mark Access Health Policy ; 9(1): 1849984, 2020 Dec 01.

Article em En | MEDLINE | ID: mdl-33312457